Zobrazeno 1 - 10
of 315
pro vyhledávání: '"Consensus interferon"'
Publikováno v:
Medical alphabet. :51-58
According to the who, the share of acute respiratory viral infections (амма? and influenza) accounts for about 90–95% of all infectious diseases; in russia, influenza and arvi take up to 40% of the total duration of official disability, which d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a0ee77a9e0418f448f8a7842619e80d
https://doi.org/10.33667/2078-5631-2021-7-51-58
https://doi.org/10.33667/2078-5631-2021-7-51-58
Autor:
Hong Chen, Li Sun, Xin Zhang, Hong Zhang, Hua Luo, Qi Zhang, Yu‑Chen Cao, Cheng‑Jiao Liu, Yan‑Fu Sun, Bin Liu, Jun‑Qi Niu, Yan‑Hua Ding
Publikováno v:
Experimental and Therapeutic Medicine
This study aimed to explore and evaluate the tolerability and antiviral activity of pegylated recombinant human consensus interferon-α (PEG-CIFN) in adults with hepatitis C virus (HCV) infection. A total of 48 adult subjects chronically infected wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3663f348738c133b774e459022cf8b7
http://europepmc.org/articles/PMC5244764
http://europepmc.org/articles/PMC5244764
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eric Dieperink, Lori Tetrick, William P. Boyd, C. Smith, Clark C. Kulig, Charles DeComarmond, Daniel P. McKee, Bashar Aqel, Marcos C. Pedrosa, Shanglei Liu, Samuel B. Ho, Edmund J. Bini, Yngve Falck-Ytter
Publikováno v:
Digestive Diseases and Sciences
Background Patients with chronic hepatitis C genotype 1 (HCV-1) and difficult-to-treat characteristics respond poorly to pegylated interferon alfa and ribavirin (RBV), and could benefit from an interferon with increased activity (consensus interferon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aa8b6502d9cfab008e6dfcf4c876626
https://doi.org/10.1007/s10620-010-1504-y
https://doi.org/10.1007/s10620-010-1504-y
Autor:
Ivanka Zic, Franklin M. Klion, David J. Clain, David E. Bernstein, Douglas F. Meyer, Henry C. Bodenheimer, Albert D. Min, Hillel Tobias, Arathi Rajendra, Edward Brettholz
Publikováno v:
Hepatitis Research and Treatment
Background. Current treatment of chronic hepatitis C with pegylated interferon and ribavirin has the ability to eliminate viral infection in about half of the patients treated. Therapeutic options, for those with remaining chronic hepatitis, will rem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a917f22c85593010fdf83056117d97e5
https://doi.org/10.1155/2010/537827
https://doi.org/10.1155/2010/537827
Autor:
Kenneth J. Resser, Kohar Sayadzadeh, Tracy Figueroa, Michael C. Klein, Myron J. Tong, Scott E. Cruickshank, Lawrence M. Blatt
Publikováno v:
Journal of Interferon & Cytokine Research. 18:81-86
To assess the safety and efficacy of consensus interferon (IFN-Con-1), 55 patients with chronic hepatitis C infection were treated with either 3, 6, 9, 12, or 15 microg IFN-Con-1 s.c. three times a week for 24 weeks, followed by 24 weeks of observati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88ee8496c715c5d993086fde5bba7949
https://doi.org/10.1089/jir.1998.18.81
https://doi.org/10.1089/jir.1998.18.81
Autor:
Yuyou Hao, Qiqi Shi, Yun He, Yingping Zhuang, Yonghong Wang, Siliang Zhang, Ju Chu, Zhimin Liu
Publikováno v:
Frontiers of Chemical Engineering in China. 1:399-403
The present work focused on the high expression of recombinant human consensus interferon-α (cIFN) by Pichia pastoris. The cycle of glycerol feeding, the strategy of methanol feeding and the optimum pH for protein induction were studied. The optimiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38e1f5b5de33d1f7ad53673bd40cd56f
https://doi.org/10.1007/s11705-007-0073-x
https://doi.org/10.1007/s11705-007-0073-x
Autor:
Kemmer, Nyingi, Neff, Guy W
Publikováno v:
Liver International
Patients with chronic hepatitis C virus (HCV) infection and disease-related complications - among them cirrhosis and liver failure - pose a particular management challenge. Some of these patients may fail to respond to current therapy (non-responders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::88a45eab76c202a2aa943e31a4ba2b78
http://europepmc.org/articles/PMC2779464
http://europepmc.org/articles/PMC2779464